Cita APA

Vitale, D. L., Caon, I., Parnigoni, A., Sevic, I., Spinelli, F. M., Icardi, A., . . . Alaniz, L. D. (2021). Initial identification of UDP-glucose dehydrogenase as a prognostic marker in breast cancer patients, which facilitates epirubicin resistance and regulates hyaluronan synthesis in MDA-MB-231 cells. Web

Citación estilo Chicago

Vitale, Daiana Luján, Ilaria Caon, Arianna Parnigoni, Ina Sevic, Fiorella Mercedes Spinelli, Antonella Icardi, Alberto Passi, Davide Vigetti, and Laura Daniela Alaniz. Initial Identification of UDP-glucose Dehydrogenase As a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells. 2021.

Cita MLA

Vitale, Daiana Luján, et al. Initial Identification of UDP-glucose Dehydrogenase As a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells. 2021.